Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: A large claims database study 2010–2019
- 1 March 2023
- journal article
- research article
- Published by Elsevier BV in Pregnancy Hypertension
- Vol. 31, 73-83
- https://doi.org/10.1016/j.preghy.2023.01.001
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancyEmergencias, 2014
- Validity of congenital malformation diagnostic codes recorded in Québec's administrative databasesPharmacoepidemiology and Drug Safety, 2013
- Patterns of Outpatient Antihypertensive Medication Use During Pregnancy in a Medicaid PopulationHypertension, 2012
- The safety of calcium channel blockers during pregnancy: A prospective, multicenter, observational studyReproductive Toxicology, 2008
- Outpatient use of cardiovascular drugs during pregnancyPharmacoepidemiology and Drug Safety, 2008
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancyPublished by Wiley ,2007
- Exposure to Amlodipine in the First Trimester of Pregnancy and During BreastfeedingHypertension in Pregnancy, 2007
- The Risk of Birth Defects in Multiple Births: A Population-Based StudyMaternal and Child Health Journal, 2005
- The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort studyAmerican Journal of Obstetrics and Gynecology, 1996
- Neonatal renal failure: A complication of maternal antihypertensive therapyAmerican Journal of Obstetrics and Gynecology, 1989